Boston Common Asset Management, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Boston Common Asset Management, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2019$7,050,000
+5.2%
80,596
-1.5%
0.87%
+4.2%
Q2 2019$6,702,000
-0.9%
81,830
-1.6%
0.84%
-4.9%
Q1 2019$6,763,000
+30.9%
83,176
+5.9%
0.88%
+16.4%
Q4 2018$5,168,000
-14.9%
78,521
-0.3%
0.75%
+0.1%
Q3 2018$6,074,000
-0.2%
78,791
-4.4%
0.75%
-0.1%
Q2 2018$6,088,000
+17.3%
82,446
+3.3%
0.75%
+23.2%
Q1 2018$5,192,000
-26.1%
79,831
-26.6%
0.61%
-26.6%
Q4 2017$7,027,000
+7.1%
108,711
+4.0%
0.83%
+2.0%
Q3 2017$6,559,000
+3.8%
104,527
+0.2%
0.82%
-1.7%
Q2 2017$6,316,000
+13.7%
104,322
-2.6%
0.83%
+10.2%
Q1 2017$5,556,000
+14.6%
107,132
-2.0%
0.76%
+6.8%
Q4 2016$4,847,000
-5.9%
109,305
+1.0%
0.71%
+152.5%
Q3 2016$5,151,000
+5.3%
108,217
+0.1%
0.28%
-0.4%
Q2 2016$4,891,000
+13.6%
108,153
+3.2%
0.28%
+15.2%
Q1 2016$4,306,000
+7.8%
104,823
+0.1%
0.24%
+8.4%
Q4 2015$3,994,000
+26.2%
104,688
+8.7%
0.22%
+16.6%
Q3 2015$3,164,000
-27.0%
96,318
+55.3%
0.19%
-16.1%
Q2 2015$4,337,000
-2.0%
62,023
-4.0%
0.23%
-2.5%
Q1 2015$4,427,000
-6.3%
64,623
+0.3%
0.24%
-10.6%
Q4 2014$4,724,000
+0.7%
64,459
-1.3%
0.26%
+0.8%
Q3 2014$4,689,000
+39.8%
65,329
+40.8%
0.26%
+43.2%
Q2 2014$3,355,000
-3.1%
46,410
-1.3%
0.18%
-6.6%
Q1 2014$3,461,000
+6.5%
47,044
+0.6%
0.20%
+8.3%
Q4 2013$3,251,000
-9.1%
46,749
-14.1%
0.18%
-12.1%
Q3 2013$3,575,000
-8.5%
54,424
-3.5%
0.21%
-15.2%
Q2 2013$3,907,00056,4060.24%
Other shareholders
BAXTER INTL INC shareholders Q3 2014
NameSharesValueWeighting ↓
GENERATION INVESTMENT MANAGEMENT LLP 21,171,371$1,817,350,0007.47%
Soditic Asset Management LLP 147,620$12,672,0006.53%
NUANCE INVESTMENTS, LLC 4,084,218$350,589,0006.17%
PRAGMA GESTAO DE PATRIMONIO LTD 145,000$12,4475.96%
Veritas Asset Management LLP 12,222,261$1,049,159,0005.89%
Pavadi Capital LLC 72,782$6,248,0004.74%
Sonen Capital LLC 48,907$4,198,0004.06%
Glenview Capital Management 2,182,422$187,339,0003.99%
Dash Acquisitions Inc. 103,963$8,924,0003.87%
Avidity Partners Management LP 1,765,000$151,508,0003.21%
View complete list of BAXTER INTL INC shareholders